Artificial Organs-Global Market Status and Trend Report 2013-2023
Report Summary
Artificial Organs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Artificial Organs worldwide, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the global Artificial Organs market as:
Global Artificial Organs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Artificial Organs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
Global Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
Global Artificial Organs Market: Manufacturers Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Artificial Organs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Artificial Organs worldwide, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the global Artificial Organs market as:
Global Artificial Organs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Artificial Organs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
Global Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
Global Artificial Organs Market: Manufacturers Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ARTIFICIAL ORGANS
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 Global Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Organs 2013-2017
2.2 Production Market of Artificial Organs by Regions
2.2.1 Production Volume of Artificial Organs by Regions
2.2.2 Production Value of Artificial Organs by Regions
2.3 Demand Market of Artificial Organs by Regions
2.4 Production and Demand Status of Artificial Organs by Regions
2.4.1 Production and Demand Status of Artificial Organs by Regions 2013-2017
2.4.2 Import and Export Status of Artificial Organs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Artificial Organs by Types
3.2 Production Value of Artificial Organs by Types
3.3 Market Forecast of Artificial Organs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Organs by Downstream Industry
4.2 Market Forecast of Artificial Organs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
5.1 Global Economy Situation and Trend Overview
5.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Artificial Organs by Major Manufacturers
6.2 Production Value of Artificial Organs by Major Manufacturers
6.3 Basic Information of Artificial Organs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Artificial Organs Major Manufacturer
6.3.2 Employees and Revenue Level of Artificial Organs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care, Inc.
7.1.1 Company profile
7.1.2 Representative Artificial Organs Product
7.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
7.2 Abiomed, Inc.
7.2.1 Company profile
7.2.2 Representative Artificial Organs Product
7.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
7.3 Asahi Kasei Medical Co., Ltd.
7.3.1 Company profile
7.3.2 Representative Artificial Organs Product
7.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
7.4 Baxter International, Inc.
7.4.1 Company profile
7.4.2 Representative Artificial Organs Product
7.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 Company profile
7.5.2 Representative Artificial Organs Product
7.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
7.6 Fresenius Medical Care AG & Co. KGaA
7.6.1 Company profile
7.6.2 Representative Artificial Organs Product
7.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
7.7 HeartWare International, Inc.
7.7.1 Company profile
7.7.2 Representative Artificial Organs Product
7.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
7.8 Jarvik Heart, Inc.
7.8.1 Company profile
7.8.2 Representative Artificial Organs Product
7.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
7.9 Medtronic, Inc.
7.9.1 Company profile
7.9.2 Representative Artificial Organs Product
7.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.10 Nikkiso Co., Ltd.
7.10.1 Company profile
7.10.2 Representative Artificial Organs Product
7.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
7.11 Nipro Corporation
7.11.1 Company profile
7.11.2 Representative Artificial Organs Product
7.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
7.12 SynCardia Systems, Inc.
7.12.1 Company profile
7.12.2 Representative Artificial Organs Product
7.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
7.13 Terumo Heart, Inc.
7.13.1 Company profile
7.13.2 Representative Artificial Organs Product
7.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
7.14 Thoratec Corp.
7.14.1 Company profile
7.14.2 Representative Artificial Organs Product
7.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
8.1 Industry Chain of Artificial Organs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
9.1 Cost Structure Analysis of Artificial Organs
9.2 Raw Materials Cost Analysis of Artificial Organs
9.3 Labor Cost Analysis of Artificial Organs
9.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL ORGANS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 Global Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Organs 2013-2017
2.2 Production Market of Artificial Organs by Regions
2.2.1 Production Volume of Artificial Organs by Regions
2.2.2 Production Value of Artificial Organs by Regions
2.3 Demand Market of Artificial Organs by Regions
2.4 Production and Demand Status of Artificial Organs by Regions
2.4.1 Production and Demand Status of Artificial Organs by Regions 2013-2017
2.4.2 Import and Export Status of Artificial Organs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Artificial Organs by Types
3.2 Production Value of Artificial Organs by Types
3.3 Market Forecast of Artificial Organs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Organs by Downstream Industry
4.2 Market Forecast of Artificial Organs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
5.1 Global Economy Situation and Trend Overview
5.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Artificial Organs by Major Manufacturers
6.2 Production Value of Artificial Organs by Major Manufacturers
6.3 Basic Information of Artificial Organs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Artificial Organs Major Manufacturer
6.3.2 Employees and Revenue Level of Artificial Organs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care, Inc.
7.1.1 Company profile
7.1.2 Representative Artificial Organs Product
7.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
7.2 Abiomed, Inc.
7.2.1 Company profile
7.2.2 Representative Artificial Organs Product
7.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
7.3 Asahi Kasei Medical Co., Ltd.
7.3.1 Company profile
7.3.2 Representative Artificial Organs Product
7.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
7.4 Baxter International, Inc.
7.4.1 Company profile
7.4.2 Representative Artificial Organs Product
7.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 Company profile
7.5.2 Representative Artificial Organs Product
7.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
7.6 Fresenius Medical Care AG & Co. KGaA
7.6.1 Company profile
7.6.2 Representative Artificial Organs Product
7.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
7.7 HeartWare International, Inc.
7.7.1 Company profile
7.7.2 Representative Artificial Organs Product
7.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
7.8 Jarvik Heart, Inc.
7.8.1 Company profile
7.8.2 Representative Artificial Organs Product
7.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
7.9 Medtronic, Inc.
7.9.1 Company profile
7.9.2 Representative Artificial Organs Product
7.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.10 Nikkiso Co., Ltd.
7.10.1 Company profile
7.10.2 Representative Artificial Organs Product
7.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
7.11 Nipro Corporation
7.11.1 Company profile
7.11.2 Representative Artificial Organs Product
7.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
7.12 SynCardia Systems, Inc.
7.12.1 Company profile
7.12.2 Representative Artificial Organs Product
7.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
7.13 Terumo Heart, Inc.
7.13.1 Company profile
7.13.2 Representative Artificial Organs Product
7.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
7.14 Thoratec Corp.
7.14.1 Company profile
7.14.2 Representative Artificial Organs Product
7.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
8.1 Industry Chain of Artificial Organs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
9.1 Cost Structure Analysis of Artificial Organs
9.2 Raw Materials Cost Analysis of Artificial Organs
9.3 Labor Cost Analysis of Artificial Organs
9.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL ORGANS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
